NZDCHF

post-image

Technical Analysis – NZDCHF undecided, finds support at 23.6% Fibonacci and 21-SMA

Posted on September 18, 2019 at 3:15 pm GMT

NZDCHF uncertain of direction has found support at 0.6280, this being the 21-day simple moving average (SMA) and the 23.6% Fibonacci retracement level of the down leg from 0.6670 to 0.6161. The restricting 42-day SMA pushed the price down after it rallied from a fourty-seven-month low of 0.6161 to the 0.6400 handle. The 21-day SMA and the MACD suggest that the short-term positive momentum has dried up. The MACD – although above its red trigger line – is in the [..]

post-image

Technical Analysis – NZDCHF moves sideways after falling to nearly 4-year lows

Posted on August 23, 2019 at 1:50 pm GMT

NZDCHF bulls denied further downside momentum on August 13 pushing the price back up to 0.6313, which is the 23.6% Fibonacci retracement level of the down wave from 0.6670 to 0.6200, and into a short-term trading range. The 20- and 40-period simple moving averages (SMAs) give no clear direction on the four-hour chart, whilst the 100-period SMA reflects the bigger bearish picture. Directional momentum has evaporated, with the MACD only slightly above its red trigger line and just below the [..]

post-image

Technical Analysis – NZDCHF’s 100-SMA and 50.0% Fibonacci become a double opponent obstacle

Posted on July 18, 2019 at 8:25 am GMT

NZDCHF saw some positive divergence in the last several weeks on the RSI which helped it to bounce back from a three-month high tumble from 0.6913 to an eight-month low of 0.6423. Since yesterday the price is trading above the 38.2% Fibonacci retracement level of the down-leg from 0.6913 to 0.6423, of 0.6614 and is heading towards the 50.0% Fibo coupled with the 100-day simple moving average (SMA) at 0.6673. The short-term SMAs of 21- and 40-days have crossed bullishly suggesting [..]

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.